Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 5/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | GSK3B | P49841 | 1/20 | 0.32 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.32 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL802210 | 0.82 | PKM (0.38) | NPC1PKMRAB9AATML3MBTL1 | |
| SCHEMBL3234536 | 0.80 | NPC1 (0.37) | NPC1PKMRAB9AATML3MBTL1 | |
| SCHEMBL20909675 | 0.78 | NPC1 (0.35) | NPC1PKMRAB9AATML3MBTL1 | |
| SCHEMBL22733836 | 0.78 | CYP2A6 (0.36) | NPC1PKMRAB9AATML3MBTL1 | |
| SCHEMBL12161061 | 0.75 | NPC1 (0.37) | NPC1PKMRAB9AATML3MBTL1 | |
| SCHEMBL13868022 | 0.75 | RIPK1 (0.39) | NPC1PKMRAB9AATML3MBTL1 | |
| SCHEMBL16254998 | 0.73 | NPC1 (0.36) | NPC1PKMRAB9AATML3MBTL1 | |
| SCHEMBL21719976 | 0.72 | ESR1 (0.34) | NPC1PKMRAB9AATML3MBTL1 | |
| SCHEMBL12238628 | 0.72 | ALOX5 (0.34) | NPC1PKMRAB9AATML3MBTL1 | |
| SCHEMBL10697065 | 0.72 | GSK3B (0.39) | NPC1PKMRAB9AATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10454034-B2 | Hexabenzocoronene-based compound for organic photovoltaic cells | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2019-10-22 | — | — | US | disclosed |
| US-20180047906-A1 | HEXABENZOCORONENE-BASED COMPOUND FOR ORGANIC PHOTOVOLTAIC CELLS | UNIVERSITE DE PAU ET DES PAYS DE L'ADOUR (FR) | 2018-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10454034-B2 | Hexabenzocoronene-based compound for organic photovoltaic cells | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, PPOX, PAX3 | NPC1 3314/4885PKM 1232/4885RAB9A 4720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.